Trials / Enrolling By Invitation
Enrolling By InvitationNCT06710626
Control of Assistive Devices Via Brain-Computer Interface Technology
CONVOY: An Early Feasibility Study of Neural Control of Assistive Devices Via Brain-Computer Interface Technology
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (estimated)
- Sponsor
- Neuralink Corp · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The CONVOY Study is a clinical trial designed to explore the feasibility of participants from the PRIME Study (NCT06429735) using the N1 Implant to control various assistive devices. The main goal is to determine whether participants can successfully modulate their brain activity to control devices, such as an Assistive Robotic Arm (ARA). This study will assess the effectiveness, consistency, and safety of neural control using the ARA and other assistive devices.
Conditions
- Tetraplegia/Tetraparesis
- Amyotrophic Lateral Sclerosis (ALS)
- Quadriplegia
- Spinal Cord Injury (SCI)
- Spinal Cord Injury Cervical
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Assistive Robotic Arm | The intervention involves using the N1 Implant, a wireless brain-computer interface (BCI), to enable participants to control the Assistive Robotic Arm through neural signals. |
Timeline
- Start date
- 2024-11-25
- Primary completion
- 2031-05-25
- Completion
- 2031-05-25
- First posted
- 2024-11-29
- Last updated
- 2025-06-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06710626. Inclusion in this directory is not an endorsement.